Key terms
About KTRA
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KTRA news
Feb 22
7:14am ET
Kintara Therapeutics Halts ATM Offerings and Equity Facility Usage
Feb 14
4:25pm ET
Kintara Therapeutics Issues Unofficial Financial Update
Feb 12
9:23am ET
Kintara Advances CMBC Treatment with REM-001 Clinical Trial
Feb 12
9:05am ET
Kintara Therapeutics initiates REM-001 15-patient clinical trial
Dec 07
9:02am ET
Kintara Therapeutics initiates review of strategic alternatives
Dec 05
9:10am ET
Kintara Therapeutics granted extension by Nasdaq to regain compliance
No recent news articles are available for KTRA
No recent press releases are available for KTRA
KTRA Financials
Key terms
Ad Feedback
KTRA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KTRA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range